Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Supreme Court deals a series of blows to generic drug companies

  • Nicholas Florko

By Nicholas Florko June 16, 2020

Reprints

It’s a bad run for generic drug companies at the Supreme Court.

The court on Monday denied three separate requests from generic drug makers hoping the justices would revisit lower-court decisions the industry doesn’t like.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Nicholas Florko

Nicholas Florko

Reporter, Commercial Determinants of Health

Nicholas Florko reports on the commercial determinants of health.

Tags

‘A game-changer’: How Vertex delivered on cystic fibrosis
‘A game-changer’: How Vertex delivered on cystic fibrosis
FDA approves first blood sugar monitor without finger pricks
FDA approves first blood sugar monitor without finger pricks
Drug used to halt puberty in children may cause…
Drug used to halt puberty in children may cause lasting health problems
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…
J&J loses a patent battle in India over a…
J&J loses a patent battle in India over a crucial tuberculosis drug

Recommended Stories